Ordensklinikum Linz GmbH — Clinical Trial Site

241 Registered trials

101 Currently recruiting

Organisation

Ordensklinikum Linz GmbH

Location

Linz, Austria

Identifier

ORG-100011398

Address

Seilerstätte 4, 4020, Austria

Departments

"Internal 2 - Cardiology, Angiology & Internal Intensive Care
(Hämato)onkologie und Hämostaseologie
#0401: Dermatologie
#2000: Department of Urology
#7001: Dermatologische Abteilung
040001: Elisabethinen - Hämatologie, Hämostaseologie, medizinische Onkologie
0404 Abteilung für Urologie und Andrologie
1. Internal Department Oncology and Hematology
1. Internen Abteilung - Hämatologie mit Stammzelltransplantation
104005: Haematologie mit Stammzelltransplantation, Hämostaseologie & medizinische Onkologie
1201: Department of Urology and Andrology
2. Internal Medicine
2000: Department of Urology
2002: Interne I: Medizinische Onkologie und Haematologie
2162_Int. Dep.
2nd Internal Department
2nd Internal Department - Cardiology, Angiology & Internal Intensive Care Medicine
Abt. Pneumologie
Abteilung fuer Urologie
Abteilung für Dermatologie
Abteilung für Dermatologie und Venerologie
Abteilung für Innere Medizin 2 - Kardiologie, Angiologie und Intensivmedizin,
Abteilung für Innere Medizin II - Kardiologie
Abteilung für Medizinische Hämatologie und Onkologie
Abteilung für Pneumologie
Abteilung für Urologie
Abteilung für Urologie und Andrologie
Abteilung Interne IV
Anaesthesiologie & Intensivmedizin
AT30001:Internal 1- Hematology
Barmherzige Schwestern
Barmherzige Schwestern, Department of HNO/Head & Neck Surgery
Cardiology
Cardiology, Angiology, Intensive Care Med
Chir. Abteilung
Clinical Department Oncology
Dep. Dermatology
Depart of Internal Medicine I Division of hemat with stem cell transplant, hemost and med oncology
Department ENT
Department for Pneumology
Department for Urology
Department Hematology and Stem Cell Transplantation
Department Internal I
Department of Dermatology
Department of Ear, Nose and Throat Disease
Department of ENT, Head and Neck Surgery
Department of ENT, head and neck surgery (HNO, Kopf- und Halschirurgie)
Department of ERT, Head and Neck surgery
Department of Gynecology
Department of Hematology and Oncology
Department of Hematology with stem cell transplantation, hemostaseology and medical oncology
Department of Hematology, hemostaseology and medical oncology; Hemato-oncological center
Department of Hematology, Stem Cell Therapy and Internal Oncology
Department of Internal Medicine
Department of Internal Medicine 2 - Cardiology, Angiology and Intensive Care
Department of Internal Medicine I
Department of Internal Medicine I - Medical Oncology and Haematolgogy
Department of Internal Medicine I - Medical Oncology and Haematology
Department of Internal Medicine I Division of medical oncology and hematology
Department of Internal Medicine I, Hemostaseology and Medical Oncology
Department of Internal Medicine I; Division of Medical Oncology and Haematology
Department of Internal Medicine I: Medical Oncology and Hematology
Department of Internal Medicine IV
Department of Internal Medicine, Hematology and Oncology
Department of Medicine I, Division of Hematology and Hemostaseology
Department of Pneumology
Department of Pneumology 2, 2B
Department of Surgery
Department of Urology
Department of Urology and Andrology
Dermatology
Division of Haematology and Oncology
Division of Internal Medicine II - Cardiology, Angiology and Internal Intensive Care Medicine
Elisabethinen I.Internal Depart., Hematology w. stem cell transpl., haemostaseology & med. oncology
Elisabethinen Hämatologie mit Stammzelltransplantation, Hämostaseoligie und med. Onkologie
Elisabethinen I. Internal Depart., Hematology w. stem cell transpl., haemostaseology & med. oncology
Elisabethinen, Department of Hematology & Oncology
Gynecology and Obstetrica
Gynecology and Obstetrics
Haematologie mit Stammzelltransplantation, Haemostaseologie und medizinische Onkologie
Haematologie/Onkologie
Haematology & Oncology
Haematology with stem cell transplantation, haemostaseology and medical oncology
Hämatologie & Onkolog
Hämatologie & Onkologie
Hämatologie mit Stammzelltransplantation, Hämostaseologie und medizinische Onkologie
Hämatologie mit stammzelltransplantation, Hämostatseologie und medizinische Onkologie
Hämatologie und Onkologie
Hämatologie/Onkologie
Hämatologisches Zentrum, Ordensklinikum Linz GmbH Elisabethinen
Hematology
Hematology and Oncology
Hematooncology
HNO, Kopf- und Halschirurgie
HNO, Kopf- und Halschirurgie, Ordensklinikum Linz Barmherzige Schwestern.
I. Internal department Hematology and Oncology
I. Interne Abteilung
I. Interne Abteilung Hämato-Onkologie
Innere Medizin 2 - Kardiologie, Angiologie und Intensivmedizin
Internal 1 - Hematology with stem cell transplantation, hemostaseology and medical oncology
Internal 2 - Cardiology, Angiology and internal Intensive Care
Internal 3 - Renal Diseases and Hypertension, Transplantation Medicine, Rheumatology
Internal Department I
Internal Department IV
Internal I
Internal I - Internal Oncology, Hematology and Gastroenterology
Internal I Medical Oncology and Hematology
Internal I, Medical Oncology and Hematology
Internal I: Medical Oncology and Hematology
Internal I: Medical Oncology and Hematology Study coordination
Internal Medicine
Internal Medicine 2 – Cardiology, Angiology and Internal Intensive Care Medicine
Internal Medicine I - Hemato-Oncology
Internal Medicine I - hematology with stem cell transplant, hemostaseology and medical oncology
Internal Medicine I: Medical Oncology and Hematology
Internal Medicine II
Internal Medicine IV
Interne - Hämatologie und Onkologie
Interne 1 - Hämatologie mit Stammzellentransplantation, Hämostaseologie und medizinische Onkologie
Interne 1 - Hämatologie mit Stammzelltransplantation, Hämostaseologie und medizinische Onkologie
Interne 1 - Hämatologie mit Stammzelltransplantation, Hämostaseologie und medizinische Onkologie
Interne 2 - Kardiologie, Angiologie & Interne Intensivmedizin
Interne 2 - Kardiologie, Angiologie und Interne Intensivmedizin
Interne 2 – Kardiologie, Angiologie & interne Intensivmedizin
Interne 4 - Gastroenterologie & Hepatologie, Stoffwechsel- & Ernährungsmedizin, Endokrinologie
Interne I
Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie
Interne I: Medical Oncology and Hematology
Interne I: Medizinische Onkologie und Haematologie
Interne I: Medizinische Onkologie und Hämatologie
Interne IV
Interne IV - Gastroenterologie & Hepatologie
Interne IV- Gastroenterologie
Kardiologie
Klinik für Urologie und Andrologie
Koop. Studiengruppe Chir./Int.
Lungenabteilung / Pneumologie
Lungenabteilung /Pneumologie
Main Centre
Medical Oncology and Hematology
Medizinische Onkologie und Haematologie
N/A
NA
Nephrologie
Nephrology
Oncology and Respiratory Tract Diseases
Oncology/Haematology
Ordensklinikum Linz - Barmherzige Schwestern
Ordensklinikum Linz Elisabethinen Abteilung 1. Interne / Onkologie / Hämatologie)
Ordensklinikum Linz Elisabethinen GmbH
Ordensklinikum Linz Elisabethinen, Internal II - Cardiology, Angiology & Intensive Care Medicine
Ordensklinikum Linz GmbG Elisabethinen Abteilung für Urologie und Andrologie
Ordensklinikum Linz GmbH - Elisabethinen Lungenabteilung / Pneumologie
Ordensklinikum Linz GmbH – Elisabethinen Lungenabteilung / Pneumologie
Ordensklinikum Linz GmbH Barmherzige Schwestern
Ordensklinikum Linz GmbH Elisabethinen Urologie
Ordensklinikum Linz GmbH Elisabethinen, Department of Pneumology.
Otorhinolaryngology, Head and Neck Surgery
Pneumologie
Pneumology
Pulmonology
Servicestelle für klinische Studien Pneumologie 2, 2B
Skin Cancer Center
Surgical Department
Urologie
Urology
Urology Department
Viszeralonkologisches Zentrum
Zentrum für Hämatologie und Stammzelltransplantation, Hämostaseologie und medizinische Onkologie

Clinical trials at this site (241)

Search interface

Study to evaluate the efficacy and safety of Durvalumab(MEDI4736) in combination with intravesical BCG for the treatment of patients diagnos… Ended

2023-505341-23-00 Non-muscle invasive bladder cancer 5 2018-07-27
A Phase 3 Study of Zanubrutinib (BGB-3111) Compared with Bendamustine plus Rituximab in Patients with Previously Untreated Chronic Lymphocyt… Ended

2023-509976-40-00 Untreated Chronic Lymphocytic Leukemia or Small Lymphoc 5 2018-05-28
PALLAS - PALbociclib CoLlaborative Adjuvant Study: A randomized phase III trial of Palbociclib with standard adjuvant endocrine therapy vers… Ended

2024-514841-12-00 To determine whether the addition of palbociclib to adj 5 2015-10-27
An international study to evaluate the safety and effectiveness of enzalutamide plus leuprolide, enzalutamide alone, and leuprolide alone in… Ended

2024-513521-23-00 Prostate Cancer 5 2015-08-19
Olaparib as adjuvant treatment in patients with germline BRCA mutated high risk HER2negative primary breast cancer. Ended

2024-511096-15-00 Breast Cancer 5 2014-08-01
A study to evaluate novel immunotherapy combinations in participants with advanced non-small cell lung cancer (NSCLC) Halted

2023-508730-34-00 Non-small cell lung cancer (NSCLC): - Locally advanced 9 2024-07-10
A study to test whether BI 1819479 improves lung function in people with idiopathic pulmonary fibrosis (IPF). Ended

2023-508395-11-00 idiopathic pulmonary fibrosis 4 2024-09-10
A study to test whether BI 1839100 improves cough in people with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis Ended

2023-510249-79-00 Progressive pulmonary fibrosis (PPF) 4 2024-09-10
A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutane… Ended

2023-504942-75-01 Moderate to Severe Allergic Rhinitis/Rhinoconjunctiviti 5 2024-08-22
A Study designed to evaluate the efficacy and safety of tiragolumab plus atezolizumab compared with placebo plus atezolizumab administered i… Ended

2023-506696-10-00 Non-Small Cell Lung Cancer 5 2024-06-18
VENLID Ended

2023-507859-29-00 Pain 6 2024-05-07
A Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Prurigo Nodularis Ended

2022-502461-23-00 Prurigo Nodularis 5 2024-02-15
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Inhalation of Seralutinib for the … Ended

2023-503614-80-00 Pulmonary Arterial Hypertension 5 2023-12-14
A large global trial to evaluate the efficacy and safety of milvexian in reducing recurrent cardiovascular events in patients after a heart … Ended

2022-501418-69-00 Acute Coronary Syndrome 5 2023-11-21
Evaluation of Lymphodepletion With ALLO-647 in Adults With R/R Large B Cell Lymphoma Receiving ALLO-501A Allogeneic CAR T Cell Therapy (EXPA… Ended

2023-503830-27-00 Large B-Cell Lymphoma (LBCL) 4 2023-10-17
A Phase IIb Randomised, Double-blind, Placebo-controlled, Multi-centre, Dose-ranging Study of AZD3427 in Participants with Heart Failure and… Ended

2022-502382-25-00 Heart Failure and Pulmonary Hypertension due to Left He 4 2023-08-24
INCB 39110-801 A Phase 2, Open-Label, Multicenter, Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Stu… Ended

2022-501661-47-00 Myelofibrosis ; postlung transplant (BOS); chronic graf 4 2023-08-23
An open-label, multi-center, dose-escalation Phase Ib study to determine the recommended phase 2 dose of APN401 in patients with advanced so… Ended

2023-504281-34-00 Adult patients with advanced solid tumors 3 2023-08-22
Clinical trial of MK-7648A in adults and children with skin cancer Ended

2022-501417-31-01 melanoma 5 2023-08-01
A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (S… Ended

2022-501752-29-00 Hidradenitis Suppurativa 5 2023-06-15
ABTECT-1 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -1 Ended

2022-500535-36-01 Moderately to severely active ulcerative colitis 5 2023-06-12
A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults with Cardiomyopathy Ended

2023-506352-24-00 Non-obstructive Hypertrophic Cardiomyopathy 5 2023-04-13
A randomized phase III non-inferiority trial assessing lenalidomide, bortezomib and dexame-thasone induction therapy with either intravenous… Ended

2024-516300-41-00 Multiple Myeloma 5 2023-03-07
Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN High Risk, Cisplatin-ineligible Participants (XRAY VISION) Ended

2023-508528-36-00 Resected squamous cell carcinoma of the head and neck 5 2022-12-16